Delivery Order 75F40119D10032-75F40119F19001

Award Date 9/23/19
Potential Completion Date 9/26/24
Potential Value $6.6M
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20993, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price delivery order contract awarded by the U.S. Food and Drug Administration (FDA) to Spaulding Clinical Research, LLC, a self-certified small disadvantaged business. The $5,454,071.53 contract is for the provision of clinical and laboratory applied regulatory science services to support the FDA's regulatory science programs and assist with regulatory decision-making across product lifecycles. The services include conducting clinical pharmacology studies, QT prolongation...
This is a firm fixed price delivery order awarded by the Food and Drug Administration (FDA), a civilian agency within the Department of Health and Human Services, to Spaulding Clinical Research, LLC, a self-certified small disadvantaged business. The $215,502.00 award is for clinical and laboratory applied regulatory science services, including conducting clinical pharmacology studies, QT prolongation and electrocardiogram studies, and providing regulatory process expertise. This work supports...
This $1,429,138.43 firm fixed price delivery order was awarded to Spaulding Clinical Research, LLC by the Food and Drug Administration (FDA), a civilian agency of the U.S. government. The delivery order was issued under Spaulding's $30 million Indefinite Delivery Indefinite Quantity (IDIQ) contract with the FDA for clinical and laboratory applied regulatory science services. The delivery order is for clinical electrocardiogram (ECG) studies to evaluate the electrophysiological effects of...
This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA), a civilian agency within the U.S. Department of Health and Human Services (HHS), to Spaulding Clinical Research, LLC, a self-certified small disadvantaged business. The contract is for a "CLINICAL ECG STUDY" with a ceiling value of $316,161.50 and a period of performance ending on February 28, 2018. The contract was awarded on August 10, 2016 and was not set-aside. Spaulding Clinical...
The U.S. Food and Drug Administration (FDA) awarded a $6,000,320.69 firm fixed price delivery order contract to Spaulding Clinical Research, LLC, a self-certified small disadvantaged business, for-profit organization, and limited liability company. The contract is for clinical pharmacology studies to support the FDA's regulatory science programs and assist in regulatory decision-making across product lifecycles. Spaulding Clinical Research performs this work at its facilities in West Bend,...
<p>This is a $9,671,431.00 Firm Fixed Price contract awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Safe Health Systems, Inc., a self-certified small disadvantaged business. The contract is for stimulating innovation in clinical evaluations and personalized medicine to improve product development and patient outcome. The contract has no set-aside designation and has an ultimate completion date of March 27, 2026.</p>
This is a $17,112.06 Firm Fixed Price delivery order awarded by the Food and Drug Administration (FDA) to Laboratory Equipment Service, LLC, a self-certified small disadvantaged business. The order is for services to maintain, repair, and certify specialized laboratory equipment and infrastructure at the FDA's White Oak Campus in Silver Spring, Maryland. This delivery order is part of two larger indefinite delivery vehicles (IDVs) that Laboratory Equipment Service holds with the FDA, valued at...
The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a Firm Fixed Price Delivery Order contract to Ihrc, Incorporated, a self-certified small disadvantaged, woman-owned business, for CVM SEOSS SERVICES. The contract has a potential value of $121,094.83 and a period of performance through May 11, 2026. This award is part of a larger indefinite delivery/indefinite quantity (ID/IQ) contract with a $49.5 million ceiling that Ihrc holds to provide the FDA...
This is a firm-fixed-price delivery order awarded by the Food and Drug Administration (FDA), a civilian agency, to Ihrc, Incorporated, a self-certified small disadvantaged and woman-owned business. The $122,162.88 order is for microbiologist services to support the development and evaluation of microbiological methods for cosmetics. The order was placed under Ihrc's $49.5 million indefinite delivery/indefinite quantity (ID/IQ) contract with the FDA to provide safety engineering, industrial...
This is a firm-fixed-price delivery order awarded by the U.S. Food and Drug Administration (FDA) to Laboratory Equipment Service, LLC, a self-certified small disadvantaged business. The contract, valued at $11,867.10, is for the provision of above-standard equipment services at the FDA's White Oak campus in Silver Spring, Maryland. This order is part of a larger $50 million single-award indefinite delivery vehicle (IDV) that is 100% set aside for small businesses, which was awarded to Laboratory...
  • 75F40119D10032
    Indefinite Delivery Contract
  • 75F40119D10032-75F40119F19001
    Delivery Order

This is a firm fixed price delivery order issued by the Food and Drug Administration (FDA), a civilian agency within the U.S. Department of Health and Human Services (HHS), to Spaulding Clinical Research, LLC, a self-certified small disadvantaged business. The $6,561,386.54 contract is for a range of clinical and laboratory applied regulatory science services that support the FDA's regulatory science programs and decision-making across product lifecycles. Services include conducting clinical pharmacology studies, QT prolongation and electrocardiogram studies for cardiac safety evaluation, and providing regulatory process expertise. This delivery order is part of a $30 million single award Indefinite Delivery Indefinite Quantity (IDIQ) contract awarded to Spaulding Clinical Research in 2019 to provide these services to the FDA through September 2024. The contract does not utilize a set-aside designation.

Generated 12/18/24, 9:32 AM